Novartis (United States) (Q331560)

From geokb

Revision as of 18:12, 9 September 2024 by Sky (talk | contribs) (‎Changed an Item: added subsidiary relationship based on OpenAlex/ROR data)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

company organization in New York, United States

NPC

Language	Label	Description	Also known as
English	Novartis (United States)	company organization in New York, United States	NPC

Statements

0 references

addresses subject

Genomic Aberrations and Treatment of Chronic Lymphocytic Leukemia

479

1 reference

https://openalex.org/I4210117619

Efficacy and Resistance in CML Treatment

476

1 reference

https://openalex.org/I4210117619

417

1 reference

https://openalex.org/I4210117619

Health Economics and Quality of Life Assessment

369

1 reference

https://openalex.org/I4210117619

Cyclin-Dependent Kinase 4/6 Inhibitors in Breast Cancer

332

1 reference

https://openalex.org/I4210117619

Diagnosis and Treatment of Heart Failure

332

1 reference

https://openalex.org/I4210117619

Computational Methods in Drug Discovery

311

1 reference

https://openalex.org/I4210117619

Chimeric Antigen Receptor T Cell Therapy

291

1 reference

https://openalex.org/I4210117619

Classification and Treatment of Spondyloarthritis

285

1 reference

https://openalex.org/I4210117619

Management of Hypertension and Cardiovascular Risk Factors

284

1 reference

https://openalex.org/I4210117619

Reciprocal Development of TH17 and Treg Cells

278

1 reference

https://openalex.org/I4210117619

Standardisation and Management of COPD

267

1 reference

https://openalex.org/I4210117619

Statistical Methods in Clinical Trials and Drug Development

258

1 reference

https://openalex.org/I4210117619

Genetic and Clinical Aspects of Hemoglobin Disorders

257

1 reference

https://openalex.org/I4210117619

Rheumatoid Arthritis Topics

235

1 reference

https://openalex.org/I4210117619

Advancements in Lung Cancer Research

235

1 reference

https://openalex.org/I4210117619

Hemophagocytic Lymphohistiocytosis and Related Disorders

233

1 reference

https://openalex.org/I4210117619

HER2 Signaling in Breast Cancer Treatment

226

1 reference

https://openalex.org/I4210117619

Management of Diabetes Mellitus and Cardiovascular Risk

217

1 reference

https://openalex.org/I4210117619

Acute Myeloid Leukemia

215

1 reference

https://openalex.org/I4210117619

Role of Fibroblast Activation in Cancer Progression

206

1 reference

https://openalex.org/I4210117619

Genomic Landscape of Cancer and Mutational Signatures

203

1 reference

https://openalex.org/I4210117619

Epidemiology and Treatment of Childhood Leukemia

200

1 reference

https://openalex.org/I4210117619

Pulmonary Drug Delivery Techniques

196

1 reference

https://openalex.org/I4210117619

Drug Metabolism and Pharmacogenomics

196

1 reference

https://openalex.org/I4210117619

coordinate location

40°42'51"N, 74°0'21"W

1 reference

https://openalex.org/I4210117619

United States of America

1 reference

https://openalex.org/I4210117619

0 references

Research Organization Registry ID

0 references

is subsidiary of

Novartis (Switzerland)

1 reference

https://openalex.org/I4210117619

Retrieved from "https://geokb.wikibase.cloud/w/index.php?title=Item:Q331560&oldid=1262908"